Herbert Boyer
<h4><a href="https://vmps.omeka.net/exhibits/show/science-public-service/science-public-service">Return to Science in the Public Service</a></h4>
Herbert Wayne "Herb" Boyer (born July 10, 1936) is a researcher and entrepreneur in biotechnology. Along with Stanley N. Cohen and Paul Berg he discovered a method to coax bacteria into producing foreign proteins, thereby jump starting the field of genetic engineering. By 1969, he performed studies on a couple of restriction enzymes of the E.coli bacterium with especially useful properties. He is recipient of the 1990 National Medal of Science, co-recipient of the 1996 LemelsonMIT Prize, and a co-founder of Genentech. He was professor at the University of California, San Francisco (UCSF) and later served as Vice President of Genentech from 1976 until his retirement in 1991
Douglas A. Lockard
https://upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Herbert_Boyer_HD2005_Winthrop_Sears_Medal.JPG/685px-Herbert_Boyer_HD2005_Winthrop_Sears_Medal.JPG
Science History Institute
June 9 2005
Douglas A. Lockard
Science History Institute
<a href="https://en.wikipedia.org/wiki/Herbert_Boyer">Wikipedia</a>
Photograph
English
Figures
Herbert Boyer, Biotech, Bacteria, Genetic Engineering, Science
United States
Dr. Emil Kakkis, American Geneticist
<h4><a href="https://vmps.omeka.net/exhibits/show/philanthropy-gallery/philanthropy-gallery">Return to Philanthropy</a></h4>
<h4><a href="https://vmps.omeka.net/exhibits/show/public-health-healthcare-galle/public-health-healthcare-galle">Return to Public Healthcare</a></h4>
Dr. Emil Kakkis is an American geneticist who works to fight against rare diseases and disorders. In 2009, Emil Kakkis created the Kakkis EveryLife Foundation in order to accelerate biotech innovation for rare diseases. This foundation would go on to initiate the CureTheProcess Campaign which is dedicated to improving the regulatory and clinical development process for rare diseases. Since its inception, over 175 patient organizations and physician society partners have endorsed the campaign. The foundation also supports projects with similar ideals, including RareArtist.org, EveryLife Art Contest, Global Genes Project, National MPS Society, Rare Disease Legislative Advocates and the SIMD’s North American Metabolic Academy (NAMA). As for Kakkis himself, he has worked with the FDA and Congress to help his goals, and this work led to the Brownback Brown Amendment to the 2010 FDA appropriation bill. The amendment required the FDA to review its rare disease regulatory policies and look for ways to improve.
Business Journals
Emil Kakkis <br /><br />Source: Emil Kakkis. (2012, August 21). In Wikipedia, The Free Encyclopedia. Retrieved October 15, 2012, from <a href="http://bit.ly/lz6mh7">http://bit.ly/lz6mh7</a>
Business Journals
Unknown
Business Journals
Business Journals
Link: <a href="https://everylifefoundation.org/wp-content/uploads/2012/09/Emil-Kakkis-Bio-9.13.12.pdf">Dr. Emil Kakkis (via EveryLife Foundation for Rare Diseases)</a>
Medium: Photograph
English
Figures
Health
Historic